Insider · CIK 0001755662
David Michael Clark
Files at FOLD (AMICUS THERAPEUTICS, INC.). First filing Nov 5, 2025, latest Dec 23, 2025.
David Michael Clark files SEC Form 4 as officer at FOLD (AMICUS THERAPEUTICS, INC.). Since Nov 5, 2025, David Michael Clark has reported 0 open-market buys worth $0 and 4 open-market sells worth $1.1M, the latest filed on Dec 23, 2025.
A track record needs three past buys with six months of prices behind them; David Michael Clark has 0, so none is measured yet.
The newest scored trade: sold $363k of FOLD on Dec 19, 2025, filed Dec 23, 2025, scored 18 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $1.1M.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | AMICUS THERAPEUTICS, INC. | $363k 25,642 shares | -9% | - | |
| 17Weak | AMICUS THERAPEUTICS, INC. | $282k 25,643 shares | -9% | - | |
| 23Weak | AMICUS THERAPEUTICS, INC. | $259k 25,643 shares | -8% | - | |
| 8Weak | AMICUS THERAPEUTICS, INC. | $244k 25,643 shares | -7% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 19, 2025 | FOLD AMICUS THERAPEUTICS INC | 25,642 0.01% of outstanding | $279k | Dec 19, 2025 | $785k |
| Dec 15, 2025 | FOLD Amicus Therapeutics, Inc. | 25,643 0.01% of outstanding | $271k | Dec 15, 2025 | $503k |
| Nov 24, 2025 | FOLD AMICUS THERAPEUTICS INC | 25,643 0.01% of outstanding | $245k | Nov 24, 2025 | $244k |
| Nov 4, 2025 | FOLD AMICUS THERAPEUTICS INC | 25,643 0.01% of outstanding | $227k | Nov 4, 2025 | none |
Transactions
Every row this insider has filed, 21 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Common Stock | -221,811 | $14.50 | $3.2M | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -84,842 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -77,134 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -91,439 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -108,266 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -105,388 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -83,221 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -125,430 | - | - | 0 | Apr 27, 2026 |
| Jan 2, 2026 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -5,381 | $14.27 | $77k | 240,309 | Jan 6, 2026 |
| Jan 3, 2026 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -18,498 | $14.27 | $264k | 221,811 | Jan 6, 2026 |
| Dec 19, 2025 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -25,642 | $14.17 | $363k | 245,690 | Dec 23, 2025 |
| Dec 15, 2025 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -25,643 | $11.00 | $282k | 271,332 | Dec 17, 2025 |
| Nov 24, 2025 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -25,643 | $10.10 | $259k | 296,975 | Nov 26, 2025 |
| Nov 4, 2025 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -25,643 | $9.51 | $244k | 322,618 | Nov 5, 2025 |
| Feb 11, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Common Stock | +52,338 | $0.00 | $0 | 368,854 | Feb 13, 2025 |
| Feb 11, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -20,593 | $9.57 | $197k | 348,261 | Feb 13, 2025 |
| Jan 2, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -5,381 | $9.31 | $50k | 261,967 | Jan 6, 2025 |
| Jan 3, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Common Stock | +69,228 | $0.00 | $0 | 331,195 | Jan 6, 2025 |
| Jan 3, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -11,987 | $9.41 | $113k | 319,208 | Jan 6, 2025 |
| Jan 4, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -2,692 | $9.41 | $25k | 316,516 | Jan 6, 2025 |
| Jan 3, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Stock Options (right to buy)derivative | +125,430 | $0.00 | $0 | 125,430 | Jan 6, 2025 |
Questions about David Michael Clark
Answered from the filings on this page, as of the latest one.
Is David Michael Clark buying or selling?
In the last 12 months David Michael Clark reported 0 open-market buys worth $0 and 4 open-market sells worth $1.1M on SEC Form 4; the latest was sold $363k of FOLD on Dec 19, 2025. Grants, option exercises and tax withholding are not counted.
How did David Michael Clark's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Michael Clark has 0.
Where does David Michael Clark file Form 4?
David Michael Clark has filed Form 4 at FOLD (AMICUS THERAPEUTICS, INC.) as Chief People Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.